Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New protocol for outbreaks of CEM
Taylorella equigenitalis, the bacterium that causes CEM, can be passed through natural mating and artificial insemination.
Highly contagious disease remains ‘a very real threat’

A new protocol has been implemented for controlling future outbreaks of contagious equine metritis (CEM) in England, Scotland and Wales.

Suspected cases must still be reported to the APHA, but the owners of affected horses will now be able to use a private equine veterinary surgeon - who has been specifically approved to deal with the disease - without official movement restrictions being imposed.

This arrangement requires compliance with control measures outlined in the Horserace Betting Levy Board’s code of practice for CEM. All associated costs will continue to be covered by the horse owner.

Taylorella equigenitalis, the bacterium that causes CEM, can be passed through natural mating and artificial insemination. It causes sub-fertility in affected mares and stallions can carry it without showing clinical signs, leading to chronic infection.

The new protocol was developed by the Equine Disease Coalition, which is chaired by World Horse Welfare and comprises representatives from the APHA, Animal Health Trust, BEVA, Defra and devolved administrations, Nottingham vet school, RSPCA and RVC.

BEVA chief executive David Mountford said: “Whilst occurrences of CEM are sporadic and we have not had any confirmed cases in the UK since 2012, it still presents a very real threat to our breeding industry.   

“Ensuring cases are treated and managed by an approved veterinary surgeon, who is fully versed in the HBLB Code of Practice, guarantees that the appropriate provisions will be taken in order to safeguard our world class breeding population.”

Professor Sidney Ricketts, joint veterinary adviser for the Thoroughbred Breeders Association, warned that while there have not been any UK cases for a number of years - largely because of compliance with the HBLB code of practice - infections are regularly found in many other countries.

“So there is a continued risk from carrier or infected mares or stallions being imported into the UK,” he added. “The new control measures are a vital tool in helping manage this risk.” 

The AHT will have a central role in the protocol, co-ordinating activities undertaken by approved vets, receiving and collating reports, initiating tracing processes off affected premises and taking responsibility for epidemiological investigations.

Horse owners and laboratories should report suspected cases to the Defra Rural Services helpline, on 03000 200 310.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.